About Kalaris
\nKalaris Therapeutics is a clinical stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases with major unmet medical needs.
\n \nKalaris’ lead asset, TH103, was developed by Lasker Award winner, Dr. Napoleone Ferrara, a pioneer in the field of VEGF research, and the inventor of Lucentis and Avastin during his time at Genentech. TH103 is a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, specifically engineered to achieve extended intraocular retention with enhanced VEGF inhibition in patients with exudative and/or neovascular retinal diseases.
\n \nIn head-to-head preclinical studies, TH103 showed more anti-VEGF activity and longer duration of activity compared to aflibercept, the current market-leading anti-VEGF agent. In a Phase 1a single ascending dose trial, TH103 was generally well tolerated and showed a potent anti-VEGF effect on functional and anatomical outcomes at 1-month post-dosing. Single dose durability signals, including pharmacokinetic analysis and retreatment results, suggest that TH103 may offer extended treatment durability outcomes after a standard four-dose loading regimen. Kalaris is currently enrolling a Phase 1b/2 Multiple Ascending Dose trial of TH103 in patients with nAMD, to help assess the safety and efficacy of repeat TH103 administration and to inform dose selection for potential Phase 3 development.
\n \nKalaris’ board of directors, management team and investors include co-founders, scientists and leaders and investors from companies that have played pivotal roles in developing retina therapeutics.
\n \nAbout nAMD
\nnAMD is a leading cause of blindness in the United States and Europe that affected an estimated 1.6 million adults in the United States in 2024. Over the past 20 years, anti-VEGF therapeutics have revolutionized the treatment of prevalent exudative and/or neovascular retinal diseases, which represented an estimated $15 billion global branded market in 2024. While clinical trials for these drugs have shown improvements in mean visual acuity, these results often are not reproduced in real-world settings. Many patients find the treatment burden to be challenging because it requires a demanding schedule of clinic visits and years of monitoring and treatments. This onerous treatment burden can lead to a lack of adherence to the frequent visit regimen and a decline in vision after initial gains.
\n \n---
\n \nThe Clinical Data Manager , in collaboration with study lead, is responsible for the oversight and execution of clinical data management activities across one or more clinical programs. This role ensures the timely delivery of high-quality, accurate, complete, and inspection-ready clinical trial data in compliance with applicable regulatory requirements, industry standards, and study timelines.
\nThis role serves as a key liaison across Clinical Operations, Biostatistics, Medical, Safety, Regulatory, Quality, CROs, and external data vendors. The Clinical Data Manager provides sponsor oversight of outsourced data management activities and drives database development, data cleaning, reconciliation, data cuts, database lock, and other data deliverables required to support clinical development and regulatory milestones.
\n \nJob Description and Specific Responsibilities
\n \nClinical Data Management Strategy & Study Execution
\nDatabase Development, Data Review & Cleaning
\nExternal Data & Reconciliation
\nCRO, Vendor & Timeline Management
\nCompliance & Inspection Readiness
\nCross-Functional Leadership
\nQualifications/Experience
\nAdditional Details
\nThis role is hybrid and will require periodic travel to clinical vendors, CRO meetings, investigator meetings, or other business-related activities. This role also requires multiple overnight days of monthly travel to on-site meetings in Berkeley Heights, NJ for clinical team and company meetings. The travel time is expected to be approximately 25% of the total working hours.
\n \nThe salary range for this position is $117,000 USD to $145,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.
\n \nIn compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and to complete the required employment eligibility verification form upon hire.
...We are supporting a growing environmental consulting firm seeking an experienced Project Geologist or Environmental Scientist to join its... ...or remediation experience ~ Bachelors degree in Geology, Environmental Science, or a related discipline ~ Experience...
...All offers of employment are contingent upon passing a pre-employment drug screening. EQUAL OPPORTUNITY EMPLOYER Union General Hospital is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, military, or veteran status, gender...
...Senior Construction Superintendent Indianapolis A well-established general contractor in Indianapolis is looking to add an experienced Construction Superintendent to their team. This is a great opportunity for someone who has a strong track record running commercial...
...appreciation events and recognition awardsEmployee wellness initiativesEmployee feedback and suggestion forums Job Description: As a Machine Operator, you will be expected to maintain and monitor our machines to make sure they continue to function properly. You will gain...
McCord Endowed Chair in Geology and Geophysics## Position Type:Faculty## Department:LSUAM Science - Department of Geology and Geophysics... ...and materials, energy, engineering, chemistry, physics, environmental science, coastal research, and the newly formed LSU Energy Institute...